Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study.

Qiao LD, Chen S, Yang Y, Zhang K, Zheng B, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, Yang WM, Zhao XK, Gao XF, Chen M, Tian Y.

BMJ Open. 2013 Dec 13;3(12):e004152. doi: 10.1136/bmjopen-2013-004152.

3.

Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.

Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ.

J Microbiol Immunol Infect. 2011 Oct;44(5):364-8. doi: 10.1016/j.jmii.2010.08.012. Epub 2011 Jan 20.

4.

[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].

de Cueto M, Hernández JR, López-Cerero L, Morillo C, Pascual A.

Enferm Infecc Microbiol Clin. 2006 Dec;24(10):613-6. Spanish.

PMID:
17194386
5.

[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].

Sun H, Chen L, Chen X, Jia X, Li N, Liu W, Tong H, Xiang R, Zhang F, Zhao H, Zhang J, Xu Y.

Zhonghua Jie He He Hu Xi Za Zhi. 2016 Jan;39(1):30-7. doi: 10.3760/cma.j.issn.1001-0939.2016.01.009. Chinese.

PMID:
26792053
6.
7.

The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.

Zykov IN, Sundsfjord A, Småbrekke L, Samuelsen Ø.

Infect Dis (Lond). 2016 Feb;48(2):99-107. doi: 10.3109/23744235.2015.1087648. Epub 2015 Sep 28.

PMID:
26414659
8.

Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.

Keepers TR, Gomez M, Celeri C, Krause KM, Biek D, Critchley I.

Infect Dis Ther. 2017 Jun;6(2):233-243. doi: 10.1007/s40121-017-0150-5. Epub 2017 Mar 11.

9.

[In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].

Hoşbul T, Ozyurt M, Baylan O, Bektöre B, Ardiç N, Ceylan S, Erdemoğlu A, Haznedaroğlu T.

Mikrobiyol Bul. 2009 Oct;43(4):645-9. Turkish.

PMID:
20084918
10.

Clinical and Laboratory Profile of Urinary Tract Infections Associated with Extended Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae.

Al Yousef SA, Younis S, Farrag E, Moussa HSh, Bayoumi FS, Ali AM.

Ann Clin Lab Sci. 2016 Jul;46(4):393-400.

PMID:
27466299
11.

[Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].

Cağan Aktaş S, Gençer S, Batırel A, Hacıseyitoğlu D, Ozer S.

Mikrobiyol Bul. 2014 Oct;48(4):545-55. Turkish.

13.

[In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin].

Hernández MS, García JA, Muñoz JL.

Rev Esp Quimioter. 2009 Mar;22(1):25-9. Spanish.

15.

A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection.

Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D.

J Infect. 2003 Feb;46(2):94-100.

PMID:
12634070
16.

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.

Arch Intern Med. 2008 Sep 22;168(17):1897-902. doi: 10.1001/archinte.168.17.1897.

PMID:
18809817
17.

In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.

Yang Q, Zhang H, Cheng J, Xu Z, Xu Y, Cao B, Kong H, Ni Y, Yu Y, Sun Z, Hu B, Huang W, Wang Y, Wu A, Feng X, Liao K, Shen D, Hu Z, Chu Y, Lu J, Su J, Gui B, Duan Q, Zhang S, Shao H.

Int J Antimicrob Agents. 2015 May;45(5):485-90. doi: 10.1016/j.ijantimicag.2014.11.012. Epub 2014 Dec 31.

PMID:
25600890
18.

Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.

Garau J.

Clin Microbiol Infect. 2008 Jan;14 Suppl 1:198-202. Review. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4.

19.

Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.

Cuevas O, Cercenado E, Gimeno M, Marín M, Coronel P, Bouza E; Spanish Urinary Tract Infection Study Group (SUTIS).

Diagn Microbiol Infect Dis. 2010 Jul;67(3):251-60. doi: 10.1016/j.diagmicrobio.2010.02.013.

PMID:
20542206
20.

Supplemental Content

Support Center